Trials / Conditions / Stage IVB Oral Cavity Squamous Cell Carcinoma

Stage IVB Oral Cavity Squamous Cell Carcinoma

5 registered clinical trials studyying Stage IVB Oral Cavity Squamous Cell Carcinoma.

Status	Trial	Sponsor	Phase
Completed	Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carc NCT03342911	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 2
Terminated	Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer NCT02827838	Wake Forest University Health Sciences	EARLY_Phase 1
Terminated	Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer NCT02388932	Case Comprehensive Cancer Center	N/A
Terminated	Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT01267240	National Cancer Institute (NCI)	Phase 2
Completed	Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429	Ohio State University Comprehensive Cancer Center	Phase 1 / Phase 2